angioG Cancer Research Results

angioG, angiogenesis: Click to Expand ⟱
Source:
Type:
Process through which new blood vessels.
Angiogenesis, the process of new blood vessel formation from pre-existing vessels, plays a crucial role in cancer progression and metastasis. Tumors require a blood supply to grow beyond a certain size and to spread to other parts of the body.
Vascular Endothelial Growth Factor (VEGF): VEGF is one of the most important pro-angiogenic factors. It stimulates endothelial cell proliferation and migration, leading to the formation of new blood vessels. Many tumors overexpress VEGF, which correlates with poor prognosis.
Hypoxia-Inducible Factor (HIF): In response to low oxygen levels (hypoxia), tumors can activate HIF, which in turn promotes the expression of VEGF and other angiogenic factors. This mechanism allows tumors to adapt to their microenvironment and sustain growth.
-Tumour development and progression beyond a size of few millimetres‐cubed crucially depends on the onset of angiogenesis, that is, the ‘angiogenic switch’


GC, Gastric Adenocarcinoma: Click to Expand ⟱
Stomach/Gastric Cancer

Scientific Papers found: Click to Expand⟱
2667- AL,    Allicin in Digestive System Cancer: From Biological Effects to Clinical Treatment
- Review, GC, NA
AntiCan↑, ChemoSen↑, angioG↓, chemoP↑, *GutMicro↑, *antiOx↑, other↝, GSH↓, Thiols↓, *ROS↓, *hepatoP↑, *Inflam↓, *NF-kB↓,
956- BBR,    Berberine inhibits HIF-1alpha expression via enhanced proteolysis
- in-vitro, Nor, HUVECs - in-vitro, GC, SCM1
Hif1a↓, angioG↓,
6336- Eug,    Eugenol induces apoptosis and inhibits invasion and angiogenesis in a rat model of gastric carcinogenesis induced by MNNG
- in-vivo, GC, NA
Apoptosis?, Bcl-2↓, Cyt‑c↝, Casp↑, TumCI↓, angioG↓, MMPs↓, VEGF↓, VEGFR1↓, TIMP2↑, RECK↑,
7294- GGB,    Ginsenoside Rg3 inhibits angiogenesis in gastric precancerous lesions through downregulation of Glut1 and Glut4
- vitro+vivo, GC, NA
angioG↓, GLUT1↓, GLUT4↓,
963- SFN,    Sulforaphane inhibits hypoxia-induced HIF-1α and VEGF expression and migration of human colon cancer cells
- in-vitro, CRC, HCT116 - in-vitro, GC, AGS
Hif1a↓, VEGF↓, angioG↓, Akt∅, ERK∅,

Showing Research Papers: 1 to 5 of 5

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1)

GSH↓, 1,   Thiols↓, 1,  

Cell Death(tgid=5)

Akt∅, 1,   Apoptosis?, 1,   Bcl-2↓, 1,   Casp↑, 1,   Cyt‑c↝, 1,  

Transcription & Epigenetics(tgid=7)

other↝, 1,  

Proliferation, Differentiation & Cell State(tgid=12)

ERK∅, 1,  

Migration(tgid=13)

MMPs↓, 1,   RECK↑, 1,   TIMP2↑, 1,   TumCI↓, 1,   VEGFR1↓, 1,  

Angiogenesis & Vasculature(tgid=14)

angioG↓, 5,   Hif1a↓, 2,   VEGF↓, 2,  

Barriers & Transport(tgid=15)

GLUT1↓, 1,   GLUT4↓, 1,  

Drug Metabolism & Resistance(tgid=21)

ChemoSen↑, 1,  

Functional Outcomes(tgid=23)

AntiCan↑, 1,   chemoP↑, 1,  
Total Targets: 22

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1)

antiOx↑, 1,   ROS↓, 1,  

Immune & Inflammatory Signaling(tgid=16)

Inflam↓, 1,   NF-kB↓, 1,  

Clinical Biomarkers(tgid=22)

GutMicro↑, 1,  

Functional Outcomes(tgid=23)

hepatoP↑, 1,  
Total Targets: 6

Scientific Paper Hit Count for: angioG, angiogenesis
1 Allicin (mainly Garlic)
1 Berberine
1 Eugenol
1 Ginkgolide B
1 Sulforaphane (mainly Broccoli)
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:28  Cells:%  prod#:%  Target#:447  State#:%  Dir#:1
wNotes=0 sortOrder:rid,rpid

 

Home Page